California to Hand Out $32 Million for Stem Cell Research Next Week
The California stem cell agency next week is expected to award as much as $32 million for late stage research and clinical trials involving therapies for arthritis of the knee, type 1 diabetes, an immunodeficiency affliction and ALS.
Also on tap for the Feb. 23 governing board meeting are concept proposals for expansion of the Alpha Clinic program along…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.